Search results
The state of oligonucleotide therapeutic manufacturing: what biopharmaceutical players need to know
Pharmaceutical Technology· 1 hour agoIn the genomic medicine toolbox, oligonucleotide therapeutics offer highly specific and effective ...
The state of the diagnostic industry: cautious optimism for the coming years
Pharmaceutical Technology· 1 hour agoAfter a challenging few years post-pandemic, industry professionals believe diagnostic testing is...
Translational research: Out of the lab, into the clinic
Pharmaceutical Technology· 1 hour agoTurning a research project into results that can directly benefit people is complex, time consuming,...
Sustainability in biopharma: The challenges of ESG 2.0
Pharmaceutical Technology· 1 hour agoBoth internal and public forces are pushing the pharmaceutical industry to become more sustainable....
Modernizing cell culture processes for the next wave of genomic medicine
Pharmaceutical Technology· 1 hour agoWith genomic medicine gaining clinical momentum, developers are looking for more robust ways to...
Buy or build: Strategies to meet demand for vaccine and viral vector production
Pharmaceutical Technology· 1 hour agoIn the mid-20th century, the successful development and large-scale production of vaccines for a...
Strategies to address the viral vector manufacturing shortage
Pharmaceutical Technology· 1 hour agoWith the exciting promise of addressing previously unmet medical needs, the rapidly growing field of...
Viral vector manufacturing: design considerations to improve commercial success
Pharmaceutical Technology· 1 hour agoViral vector manufacturing: the key to the success of gene therapy Frost & Sullivan recently invited...
Sponsors must take on FDA’s diversity guidance to improve community trust
Medical Device Network· 2 hours agoWith data still showing that ethnic minorities account for less than 40% of US trial populations,...
EAN 2024: encouraging analyses of pridopidine Healey ALS platform trial
Clinical Trials Arena· 2 hours agoAccording to GlobalData’s Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast –...